Replimune Group Inc (REPL)
10.80
-0.60
(-5.26%)
USD |
NASDAQ |
Nov 15, 16:00
10.80
0.00 (0.00%)
After-Hours: 20:00
Replimune Group Market Cap: 738.91M for Nov. 15, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 15, 2024 | 738.91M |
| November 14, 2024 | 779.96M |
| November 13, 2024 | 799.80M |
| November 12, 2024 | 834.01M |
| November 11, 2024 | 855.22M |
| November 08, 2024 | 849.92M |
| November 07, 2024 | 834.20M |
| November 06, 2024 | 867.68M |
| November 05, 2024 | 821.22M |
| November 04, 2024 | 821.22M |
| November 01, 2024 | 813.02M |
| October 31, 2024 | 803.46M |
| October 30, 2024 | 827.37M |
| October 29, 2024 | 838.99M |
| October 28, 2024 | 823.27M |
| October 25, 2024 | 801.41M |
| October 24, 2024 | 817.12M |
| October 23, 2024 | 820.54M |
| October 22, 2024 | 817.81M |
| October 21, 2024 | 775.45M |
| October 18, 2024 | 787.75M |
| October 17, 2024 | 772.72M |
| October 16, 2024 | 779.55M |
| October 15, 2024 | 720.11M |
| October 14, 2024 | 728.99M |
| Date | Value |
|---|---|
| October 11, 2024 | 784.33M |
| October 10, 2024 | 759.73M |
| October 09, 2024 | 804.83M |
| October 08, 2024 | 802.09M |
| October 07, 2024 | 774.08M |
| October 04, 2024 | 789.80M |
| October 03, 2024 | 798.68M |
| October 02, 2024 | 838.30M |
| October 01, 2024 | 813.02M |
| September 30, 2024 | 748.80M |
| September 27, 2024 | 762.47M |
| September 26, 2024 | 760.42M |
| September 25, 2024 | 756.32M |
| September 24, 2024 | 756.32M |
| September 23, 2024 | 748.80M |
| September 20, 2024 | 745.39M |
| September 19, 2024 | 767.25M |
| September 18, 2024 | 757.00M |
| September 17, 2024 | 753.58M |
| September 16, 2024 | 714.64M |
| September 13, 2024 | 760.42M |
| September 12, 2024 | 709.18M |
| September 11, 2024 | 708.49M |
| September 10, 2024 | 706.44M |
| September 09, 2024 | 719.42M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
307.69M
Minimum
May 29 2024
2.420B
Maximum
Dec 01 2020
1.027B
Average
935.95M
Median
Market Cap Benchmarks
| Bristol-Myers Squibb Co | 114.02B |
| Nuvalent Inc | 6.173B |
| NovaBay Pharmaceuticals Inc | 3.482M |
| Palatin Technologies Inc | 18.26M |
| iBio Inc | 19.69M |
Market Cap Related Metrics
| Price to Book Value | 1.937 |
| Price | 10.80 |
| Earnings Yield | -28.24% |